Decreased expression of GBA3 correlates with a poor prognosis in hepatocellular carcinoma patients.

In conclusion, the decreased GBA3 expression is strongly associated with a poor prognosis in HCC patients, and GBA3 may be a potential therapeutic target for HCC.
PMID: 32412773 [PubMed - as supplied by publisher]

Source: Neoplasma - May 14, 2020 Category: Cancer & Oncology Authors: Ying JF, Zhang YN, Song SS, Hu ZM, He XL, Pan HY, Zhang CW, Wang HJ, Li WF, Mou XZ Tags: Neoplasma Source Type: research